The Hermelin Brain Tumor Center is the leader in brain tumor research and treatment in Michigan for the past 20 years and among the top centers in the U.S., treating 750 new brain tumor patients and provides 2,750 Brain Tumor Board evaluations. In total the Center conducts 7,800 brain tumor patient visits annually. The Center was one of only 12 nationally and a founding member of the NIH-sponsored Adult Brain Tumor Consortium. As one of the top three largest brain tumor banks globally, the Hermelin Center was one of the largest contributors to The Cancer Genome Atlas. The Center also offers intraoperative MRI for more complete tumor resection and clinical trials not available for adults elsewhere in Michigan.
For patient’s convenience, Hermelin Brain Tumor Center offers guaranteed appointments within 24 business hours with a neurosurgeon or neuro-oncologist. Within the same week, a comprehensive treatment plan is designed and tailored to the needs of the patient and family. Immediate access is provided for brain tumor patients at any point during their care.